CDK5 Inhibitor Seliciclib Promotes Osteoblastic Differentiation of MSCs and Suppresses the Migration of MG-63 Osteosarcoma CellsHong En Fu, Tailin Guo|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 2